PSMD8 antibody
Quick Overview for PSMD8 antibody (ABIN1386252)
Target
See all PSMD8 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human, Mouse, Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human PSMD8
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
IHC-P 1:200-400
IF(IHC-P) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- PSMD8 (Proteasome (Prosome, Macropain) 26S Subunit, Non-ATPase, 8 (PSMD8))
-
Alternative Name
- PSMD8
-
Background
-
Synonyms: 26S proteasome non ATPase regulatory subunit 8, 26S proteasome non-ATPase regulatory subunit 8, 26S proteasome regulatory subunit p31, 26S proteasome regulatory subunit RPN12, 26S proteasome regulatory subunit S14, AAV38494, HIP6, HYPF, MGC1660, Nin1p, P31, Proteasome prosome macropain 26S subunit non ATPase 8, PSMD8, PSMD8_HUMAN, Rpn12, S14.
Background: Acts as a regulatory subunit of the 26S proteasome which is involved in the ATP-dependent degradation of ubiquitinated proteins. Necessary for activation of the CDC28 kinase.
-
Gene ID
- 5714
-
Pathways
- Mitotic G1-G1/S Phases, DNA Replication, Proton Transport, Synthesis of DNA, SARS-CoV-2 Protein Interactome, Ubiquitin Proteasome Pathway
Target
-